Clinical Trial Update: Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial update indicating completion of a study evaluating ibandronic acid (R484iv) for primary osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Ibandronic acid (ibandronic acid)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Primary Osteoporosis | Phase 3 | Status: COMPLETED